No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SLP240517C40000
- 10.20
- 0.000.00%
15min DelayClose May 17 14:33 ET
0.00High0.00Low
0.00Open10.20Pre Close0 Volume0 Open Interest40.00Strike Price0.00Turnover2931.37%IV0.44%PremiumMay 17, 2024Expiry Date9.98Intrinsic Value100Multiplier-4DDays to Expiry0.22Time Value100Contract SizeAmericanOptions Type0.8808Delta0.0172Gamma4.90Leverage Ratio-52.3615Theta0.0000Rho4.32Eff Leverage0.0008Vega
Intraday
- 5D
- 1D
News
Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that
Craig-Hallum Reaffirms Their Buy Rating on Simulations Plus (SLP)
Director Daniel Weiner Sells 3,000 Shares of Simulations Plus Inc (SLP)
Simulations Plus(SLP.US) Director Sells US$25,000 in Common Stock
$Simulations Plus(SLP.US)$ Director LaVange Lisa sold 500 shares of common stock on May 14, 2024 at an average price of $50 for a total value of $25,000.Source: Announcement What is statement of chang
Simulations Plus(SLP.US) Director Sells US$150.39K in Common Stock
$Simulations Plus(SLP.US)$ Director WEINER DANIEL L sold 3,000 shares of common stock on May 14, 2024 at an average price of $50.13 for a total value of $150.39K.Source: Announcement What is statement
Simulations Plus Releases GastroPlus X, The Next Generation PBPK/PBBM Modeling & Simulation Software
Redesigned platform offers ease-of-use, enhanced software engineering, and significant productivity gains for users Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of modeling and simulation solutions for the
Comments
Simulations Plus' high P/E ratio is likely due to investor expectations of strong future growth, despite stagnant earnings over the past three years. Investors seem willing to pay a premium for the stock in anticipation of its superior earnings outlook.
Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price Matching Investor OpinionSimulations plus demonstrates efficient use of profits alongside solid earnings growth, but lower ROE compared to industry average is worrisome. Still, analysts predict further earnings growth.
Kenanga Research suggests SLP Resources' performance may continue to struggle due to weak export demand and rising competition. Strong financial position and high-margin products are anticipated to maintain stability, despite Hong Leong Bank's indication of weak demand in Japan, SLP's primary market.
$Abacus Life(ABL.US$ $Ameresco(AMRC.US$ $Applied Digital(APLD.US$ $Caribou Biosciences(CRBU.US$ $Duke Energy(DUK.US$ $EdtechX Acquisition(EDTX.US$ $Genius Sports(GENI.US$ $Gorilla Technology(GRRR.US$ $Joby Aviation(JOBY.US$ $Kazia Therapeutics(KZIA.US$ $Perion Network(PERI.US$ $Pfizer(PFE.US$ $Polestar Automotive(PSNY.US$ $Simulations Plus(SLP.US$ $VBI Vaccines(VBIV.US$
3
1
$Simulations Plus(SLP.US$ Cramer’s lightning round: I can’t recommend Simulations Plus.
3
Read more